LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
$ 398,000
Dollar Stores for Sale
Grocery Stores & Delis for Sale
Transport & Shipping Businesses for Sale
Travel Businesses for Sale
Service Businesses for Sale
Gift & Flower Shops for Sale
Warehouse & Storage Businesses for Sale
Consulting & Training Businesses for Sale
Vending & Kiosk Businesses for Sale
Healthcare & Medical Businesses for Sale
Wholesale & Distribution Franchise Opportunities
Travel Franchise Opportunities
Clothing & Shoe Store Franchise Opportunities
Consultancy & Training Franchise Opportunities
Transport & Shipping Franchise Opportunities
Liquor Franchises for Sale
Employment & Personnel Franchise Opportunities
Healthcare & Medical Franchise Opportunities
Printing, Signs & Publishing Franchise Opportunities
Beauty & Personal Care Franchises for Sale
Commercial Spaces for Sale or Lease
Industrial Buildings for Sale or Lease
Office Buildings for Sale or Rent
Medical Office Spaces for Sale or Rent
Plazas for Sale
Houses & Condos for Sale or Lease
Places of Worship for Sale
Commercial Buildings for Sale or Lease
Miscellaneous Properties for Sale or Lease
Retail Buildings for Sale or Lease
An email will be sent to registered email address.
Please select if you are: